Neuroblastoma Cells Expressing the Noradrenaline Transporter Are Destroyed More Selectively by 6‐Fluorodopamine than by 6‐Hydroxydopamine
Authors:
- Gabriele SeitzGSGabriele Seitz
- Hartmut B StegmannHSHartmut B Stegmann
- Heidrun H JägerHJHeidrun H Jäger
- Hans M SchludeHSHans M Schlude
- Hartwig WolburgHWHartwig Wolburg
- Vitaly A RoginskyVRVitaly A Roginsky
- Dietrich NiethammerDNDietrich Niethammer
- Gernot BrucheltGBGernot Bruchelt
Open Access
- 1 August 2000
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 75 (2) , 511-520
Abstract
6‐Hydroxydopamine (6‐OHDA) has been used for lesioning catecholaminergic neurons and attempted purging of neuroblastoma cells from hematopoietic stem cells in autologous bone marrow transplantation (ABMT). Neurotoxicity is mediated primarily by reactive oxygen species. In ABMT, 6‐OHDA, as a purging agent, has been unsuccessful. At physiological pH it autooxidizes before targeted uptake, resulting in nonspecific cytotoxicity of nontarget cells. A catecholamine analogue, similar to 6‐OHDA but with a lower rate of autooxidation enabling uptake by target cells, is thus required. Electron paramagnetic resonance spectra in this study show that 6‐fluorodopamine (6‐FDA) hydrolyzes slowly to 6‐OHDA at physiological pH. Oxygen consumption, H2O2, and quinone production are found to be intermediate between those of 6‐OHDA and dopamine (DA). Relative neurotoxicity of these compounds was assessed by cell viability and DNA damage in the human neuroblastoma lines SH‐SY5Y and SK‐N‐LO, which express and lack the noradrenaline transporter, respectively. Specific uptake of DA and 6‐FDA by SH‐SY5Y cells was demonstrated by competitive m‐[131I]iodobenzylguanidine uptake inhibition. The competition by 6‐OHDA was low owing to rapid autooxidation during incubation with equal toxicity toward both cell types. 6‐FDA toxicity was preferential for SH‐SY5Y cells and reduced in the presence of desipramine, a catecholamine uptake inhibitor. We demonstrate that 6‐FDA cytotoxicity is more specific for cells expressing catecholamine reuptake systems than is 6‐OHDA cytotoxicity.Keywords
This publication has 26 references indexed in Scilit:
- Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sortingBone Marrow Transplantation, 1998
- Detection of Neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT–PCR and anti-Ganglioside GD2 immunocytochemistryEuropean Journal of Cancer, 1997
- Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: Correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expressionEuropean Journal of Cancer, 1995
- Expression of mdrl, mrp, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemiasBritish Journal of Haematology, 1995
- Biochemical and Immunocytochemical Changes Induced by Intrastriatal 6-Hydroxydopamine Injection in the Rat Nigrostriatal Dopamine Neuron System: Evidence for Cell Death in the Substantia NigraExperimental Neurology, 1994
- High-dose melphalan with 6-hydroxydopamine–purged autologous bone marrow transplantation for poor-risk neuroblastomaCancer, 1991
- In vitro therapeutic targeting of neuroblastomas using 125I‐labelled meta‐iodobenzylguanidineInternational Journal of Cancer, 1990
- An improved synthesis of 4-fluoroveratrole. Efficient route to 6-fluoroveratraldehyde and 6-fluoro-D,L-DOPAThe Journal of Organic Chemistry, 1986
- The role of reactive oxygen compounds derived from 6-hydroxydopamine for bone marrow purging from neuroblastoma cellsBiochemical and Biophysical Research Communications, 1985
- Synthesis and biological properties of 2-, 5-, and 6-fluoronorepinephrinesJournal of Medicinal Chemistry, 1979